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Abstract Mitochondria are known to play a fundamental role
in apoptosis by releasing apoptogenic molecules such as cyto-
chrome c into the cytoplasm, thereby sequentially activating
initiator caspase-9. However, the mechanisms of cytochrome c
release or caspase-9 activation in response to hypoxia are un-
clear. In this report, we show that caspase-9 is activated by
reactive oxygen species (ROS) without involvement of cyto-
chrome c release in hypoxic injury. In addition, activated cas-
pase-9 induces permeability transition (PT)-independent cyto-
chrome c release, suggesting that caspase-9 may disrupt
mitochondrial di¡usion limit of cytochrome c and serve to am-
plify further release of cytochrome c.
* 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Cells undergo numerous changes in gene transcription, en-
zyme activities, and mitochondrial function in response to
hypoxia [1]. On exposure to severe hypoxia beyond cellular
adaptive capability, cells are irreversibly injured and die in
necrosis or apoptosis. A large body of evidence suggests
that mitochondria play crucial roles in hypoxic cell death
passively by the inability to synthesize adenosine triphosphate
(ATP) or actively by releasing proapoptotic molecules such as
cytochrome c into the cytoplasm [2,3]. On entry into the cy-
toplasm, cytochrome c, together with dATP and apoptotic
protease activating factor-1 (Apaf-1), recruits and cleaves
pro-caspase-9 into active caspase-9 [4]. Activated caspase-9,
in turn, cleaves e¡ector caspases such as caspase-3, -6, and
-7 [5]. Thus, cytochrome c release is a key step for activation
of pro-caspase-9 in apoptotic cell death. However, even
though several models of release have been proposed [6,7],
the molecular mechanisms of cytochrome c release in response
to hypoxia are not clear.
Caspases are principal e¡ectors of apoptosis and can be
categorized into initiator and e¡ector on the basis of their
positions in the apoptotic cascades [8]. The initiator caspases
are activated in the earlier phase of apoptosis and cleave ef-
fector caspases into active forms, which are responsible for
dismantling cells [5]. Activation cascades of initiator caspases
have been delineated into two forms, death receptor-associ-
ated pathway and mitochondrial pathway. The ¢rst pathway
links cell surface receptors such as Fas or tumor necrosis
factor receptor (TNFR) to initiator caspase, caspase-8 [9,10].
The second pathway is responsible for apoptosis induced by
diverse extra- and intra-cellular stresses such as hypoxia and
growth factor withdrawal [11,12]. However, accumulating evi-
dences show that caspase-9, an initiator caspase of mitochon-
drial pathway, can be activated without involvement of cyto-
chrome c. For example caspase-12 or caspase-3 directly
cleaves pro-caspase-9 to active form [13,14].
We performed this work to understand the mechanisms of
caspase-9 activation and cytochrome c release in response to
hypoxia. In this report, we show that reactive oxygen species
(ROS) activate caspase-9 antecedent to cytochrome c release.
In addition, activated caspase-9 is required for cytochrome c
release from mitochondria. Our data propose the possibility
that pre-activated cytosolic caspase-9 ampli¢es cytochrome c
release cascade from mitochondria by disruption of mitochon-
drial di¡usion barrier.
2. Materials and methods
2.1. Reagents, cell culture and hypoxic condition
Caspase inhibitors, recombinant caspase-9, and caspase-3 assay kit
were purchased from Calbiochem (San Diego, CA, USA). All other
chemicals were ordered from Sigma unless otherwise speci¢ed. SK-N-
MC cells were obtained from the American Type Culture Collection
(Rockville, MD, USA) and cultured in a 37‡C, CO2 incubator, with
RPMI 1640 medium (Gibco BRL, CA, USA) containing 10% heat-
inactivated fetal bovine serum. For hypoxic condition, cells in de-
gassed serum- and glucose-de¢cient medium were transferred to a
hypoxic chamber with 94.5% N2/0.5% O2/5% CO2 for indicated times.
2.2. Cell fractionation and immunoblot
SK-N-MC cells were treated or untreated with caspase inhibitors
and subjected to hypoxic condition for indicated times. The harvested
cells were washed and suspended in hypotonic solution (10 mM
Hank’s balanced salt solution (HBSS), 10 mM MgCl2, 42 mM KCl)
for 5 min on ice, and passed through a 30-gage needle. The cytosolic
fraction was obtained by centrifugation at 150 000Ug for 1 h. The
proteins obtained from cytosolic fraction or whole cell lysates were
separated using 12% sodium dodecyl sulfate (SDS)^polyacrylamide
gels and transferred to nitrocellulose membrane. The blots were incu-
bated with anti-cleaved caspase-9, anti-caspase-8, anti-caspase-3 (Cell
Signaling Tech., MA, USA), or anti-cytochrome c (BD-Pharmingen,
CA, USA) antibody, followed by electrochemoluminescent (ECL)-
based detection (Amersham Pharmacia Biotech., NJ, USA).
2.3. Isolation of mitochondria
Mitochondria were freshly isolated from SK-N-MC cells by di¡er-
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ential centrifugation, as described previously [15]. The isolated mito-
chondria were washed and resuspended in respiration bu¡er (10 mM
HEPES-KOH, pH 7.4, 0.3 M mannitol, 5 mM KH2PO4, 10 mM
sodium succinate, 1 mM ethyleneglycol-bis-(L-aminoethylether)-
N,N,NP,NP-tetraacetic acid (EGTA)) and used within 4 h. Exposure
of isolated mitochondria to caspase-9 was performed in PT-1 bu¡er
(2 mM HEPES, pH 7.4, 5 mM KH2PO4, 2 WM rotenone, 250 mM
sucrose, and 4.2 mM potassium succinate) [16].
2.4. Determination of mitochondrial membrane potential (MMP)
The SK-N-MC cells were cultured in the indicated condition and
then Mitotracker Red CMXRos (Molecular Probes, Inc., OR, USA)
was added to the media at a ¢nal concentration of 400 nM. After
20 min of incubation, the cells were harvested and washed three times
with phosphate-bu¡ered saline (PBS). The £uorescent intensity was
measured by £ow cytometry (FACScaliver, Becton Dickinson, CA,
USA) using the CellQuest program.
2.5. Caspase cleavage assay
Caspase-3 activity was measured using the Colorimetric Caspase-3
Assay Kit (Calbiochem) according to the manufacturer’s instruction.
Caspase-9 activity was measured using colorimetric Ac-LEHD-pNA
substrate in the presence or absence of caspase-9 inhibitor LEHD-
CHO. Brie£y, 50 Wl cell lysates were obtained from 106 cells in lysis
bu¡er (50 mM HEPES, pH 7.4, 100 mM NaCl, 0.1% 3[3-cholamino-
propyl diethylammonio]-1-propane sulfonate (CHAPS), 1 mM dithio-
threitol (DTT), 0.1 mM ethylenediamine tetraacetic acid (EDTA)),
incubated for 5 min on ice, and then centrifuged at 10 000Ug for
10 min at 4‡C. The supernatants were incubated with Ac-LEHD-
pNA substrate in the presence or absence of caspase-9 inhibitor. Ab-
sorbance at 405 nm was determined V6 h following initiation of the
reaction. Activity was expressed as fold(s) change over control once
corrected for baseline (protein and bu¡er without colorimetric sub-
strate).
3. Results and discussion
Hypoxia is known to trigger apoptotic or necrotic cell
death, depending on type or status of the cells. Initially, in
an attempt to delineate the nature of cell death in our hypoxic
experimental system, we characterized the cell death based on
morphologic changes and caspase cleavage assay. SK-N-MC
cells exposed to hypoxic condition for 9 h demonstrated char-
acteristic nuclear condensation with fragmentations (Fig. 1A)
and increase of caspase-3 activity (Fig. 1B). These ¢ndings
indicate that SK-N-MC cells undergo apoptosis in hypoxic
condition. Mitochondria play pivotal roles in hypoxia-induced
apoptosis by releasing apoptogenic molecules such as cyto-
chrome c and apoptosis-inducing factor (AIF) [2,3]. On entry
into the cytoplasm, cytochrome c, together with dATP and
Apaf-1, recruits and cleaves pro-caspase-9 into active caspase-
9 [4]. Thus, it is conceivable that mitochondrial perturbation
(loss of MMP) with resultant cytochrome c release precedes
caspase-9 activation. To clarify these sequential events on the
base of the time course, we exposed SK-N-MC cells to hyp-
oxia for varying time points and determined apoptotic param-
eters including MMP, cytochrome c release and caspase acti-
vation from 1 h of hypoxia. Loss of MMP, determined by
potential-dependent Mitotracker, was initially observed after
6 h of hypoxia (Fig. 2A). Interestingly, we found cleaved
caspase-9 and cytochrome c release from 3 and 4 h of hypox-
ia, respectively (Fig. 2B). These time points are antecedent to
mitochondrial perturbation or activation of death receptor-
associated caspase (caspase-8) and e¡ector caspase (caspase-
3) (Fig. 2B). Our data contradict to typical mitochondrial
apoptotic cascades in which mitochondrial permeability tran-
sition (PT) induces cytochrome c release and caspase activa-
tion. However, we cannot completely discard the possibility
that small amounts of cytochrome c under detection limit of
immunoblot were released to activate caspase-9. Based on our
observation, we hypothesized that (i) cytochrome c is released
from mitochondria through permeability transition pore
(PTP)-independent pathway and (ii) caspase-9 is activated
without involvement of cytochrome c release in response to
hypoxia. To validate this hypothesis, we exposed SK-N-MC
cells to hypoxia with PT inhibitor 20 WM cyclosporin A (CsA)
or 100 WM bonkrekic acid (BA) and determined apoptotic
parameters including MMP, cytochrome c release, and cas-
pase activity. PT inhibitors suppressed dissipation of MMP
whereas they did not block cytochrome c release and cas-
pase-9 activation in hypoxia (Fig. 2C and D, left panels). In
comparison, PT inhibitors suppressed all apoptotic parame-
ters in ceramide-treated cells (Fig. 2C and D, right panels).
Ceramide is known to facilitate apoptosis via typical mito-
chondrial cascades, sequentially inducing dissipation of
MMP, cytochrome c release, and caspase-9 activation [17].
Taken together, our results indicate that hypoxia induced cy-
tochrome c release independently of PT. Opening of PTP in-
duces leakages of proapoptotic molecules such as cytochrome
c and AIF, which is the obligatory step for mitochondrial
cascades of apoptotic processes. However, it is controversial
that cytochrome c releases by proapoptotic proteins are oblig-
atorily related to opening of PTP. For example, some re-
searchers found that Bax induced opening of PTP with resul-
tant cytochrome c release [18,19], whereas others discarded
this concept because they found that Bax formed large con-
duct channels on outer mitochondrial membrane independent
Fig. 1. Hypoxia induces apoptosis in SK-N-MC cells. A: SK-N-MC
cells were exposed to hypoxia (0.5% O2) for 9 h, harvested, and
stained with 4,6-diamino-2-phenylindole (DAPI). Morphologic
changes were analyzed using £uorescence microscope. B: Cells were
exposed to hypoxia for indicated time point and harvested. Cas-
pase-3 cleavage assay using Ac-DEVD-pNA was performed accord-
ing to manufacturer’s instruction. Relative enzyme activities to nor-
moxic cells were plotted. MeansSS.E.M. of three independent
experiments are shown.
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of PTP opening [20,21]. In addition, it has been reported that
BH3-only members of Bcl-2 family proteins induced cyto-
chrome c release without MMP loss [22,23]. Next, we wished
to address the possibility of caspase-9 activation prior to cy-
tochrome c release. There can be several possible mechanisms
for caspase-9 activation without involvement of cytochrome c
release: (i) the activation of caspase-9 by endoplasmic retic-
ulum (ER)-speci¢c caspase-12 [13], (ii) direct activation by
cytosolic caspase-3 [14], (iii) the activation of other cellular
proteases such as calpain, which eventually can cleave pro-
caspase-9 [24], or (iv) unknown pathways as can be seen in
Sendai virus-infected cells [25]. To elucidate the possibilities of
caspase-12 or -3 involvement, we performed Western blots for
detection of caspase-12 or -3 cleavage product in hypoxic in-
jury. However, we could not ¢nd any evidence of caspase-3 or
-12 activation prior to caspase-9 activation (Fig. 2B and data
not shown). Hypoxic signals increase generation of ROS,
which mediates cell injury. Therefore, we determined changes
of ROS levels using ROS-sensitive dichlorodihydro£uorescein
diacetate (DCFH-DA) dyes and found increased £uorescent
intensities from 2 h of hypoxia as compared to normoxia (Fig.
3A). 500 WM N-acetylcysteine (NAC) inhibited increase of
ROS levels induced by hypoxia (Fig. 3A). To address the roles
of ROS in caspase-9 cleavage, we performed caspase-9 cleav-
age assay. Caspase-9 activity was detected from 3 h of hyp-
oxia in NAC-untreated cells whereas activity was not detected
in NAC-treated cells (Fig. 3B), indicating that hypoxia in-
duced caspase-9 activation in a ROS-dependent manner. To
reinforce our results, we treated SK-N-MC cells with 200 WM
H2O2 and determined time sequential correlation between cy-
tochrome c release and caspase-9 activation. Caspase-9 cleav-
age products were detected from 2 h of oxidative stress, which
was antecedent to cytochrome c release (Fig. 3C). Taken to-
gether, our results demonstrate that ROS is crucial in cyto-
chrome c-independent caspase-9 activation in hypoxic injury.
Further, we investigated the e¡ects of caspase-9 activation on
Fig. 2. Hypoxia induces caspase-9 activation prior to perturbation of MMP and cytochrome c release in PT-independent pathway. A: SK-N-
MC cells were exposed to hypoxia for indicated times and incubated with 400 nM Mitotracker for 20 min. After washing three times, MMP
was determined by FACScan using CellQuest program. B: Cells were exposed to hypoxia for indicated times and then cytosolic compartment
was fractionated by centrifugation as described in Section 2. Proteins were separated by 12% SDS^polyacrylamide gel electrophoresis (PAGE)
and immunoblotted with anti-cleaved caspase-9, anti-caspase-3, anti-caspase-8, or anti-cytochrome c antibody. Cleaved products of caspase-3
and -8 were shown. C: Cells treated or untreated with 20 WM CsA or 100 WM BA were exposed to hypoxia (left panel) for 6 h or 10 WM cer-
amide (right panel) for 4 h. MMP was determined as above. D: Cells were treated as in C for indicated time points. Immunoblots for cytosolic
cytochrome c or cleaved caspase-9 were performed.
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cytochrome c release from mitochondria in order to clarify the
mechanism of cytochrome c release in response to hypoxia.
We treated or untreated SK-N-MC cells with caspase inhib-
itors (20 WM LEHD-CHO for caspase-9, 40 WM DEVD-CHO
for caspase-3, and 20 WM Ac-VAD-CHO for pan-caspase in-
hibitor) prior to hypoxic stress and determined cytochrome c
translocation and MMP. LEHD-CHO or Ac-VAD-CHO in-
hibited dissipation of MMP (Fig. 4A, left panel) and cyto-
chrome c release (Fig. 4B, left panel) in hypoxia-exposed cells,
suggesting that mitochondrial perturbation cascades were
downstream to caspase-9 activation in hypoxia. Interestingly,
all caspase inhibitors failed to inhibit loss of MMP (Fig. 4A,
right panel) and cytochrome c release (Fig. 4B, right panel) in
ceramide-treated cells. Our data suggest that hypoxia induces
apoptosis di¡erently from typical mitochondrial cascades. To
further examine whether caspase-9 directly induces cyto-
chrome c release from mitochondria, we exposed the isolated
mitochondria from SK-N-MC to recombinant caspase-9 in
the presence or absence of caspase-9 inhibitor Ac-LEHD-
CMK or CsA. After incubation of 15 min, mitochondrial
compartment was removed by centrifugation and cytochrome
c release was determined by Western blot analysis. As shown
in Fig. 4C, caspase-9 induced CsA-independent cytochrome c
release from isolated mitochondria, which was inhibited by
caspase-9 inhibitor Ac-LEHD-CMK. Our results indicate
that cytochrome c was directly released by caspase-9 through
PT-independent pathway. Recently it has been reported that
in addition to cleavage of subsequent e¡ector caspases, cas-
pase-9 increases the di¡usion limit of the nuclear pores, which
allows large molecules including caspase-3 that cannot pass
through the nuclear pores to enter the nucleus [7]. Considering
the roles of caspase-9 in cellular disassembly, it may disrupt
mitochondrial barrier to release cytochrome c in hypoxic in-
jury or induce opening of cytochrome c-speci¢c pores, which
remain to be elucidated. To date, it has been reported that
recombinant caspase-3 directly induced cytochrome c release
from isolated mitochondria by PTP opening [16]. However,
the molecular mechanism of caspase-9 to induce cytochrome c
release seems to be distinct from that of caspase-3 since cas-
pase-9 induced in vitro cytochrome c release through PTP-
independent pathway. In conclusion, we report here that hy-
poxic signals induce caspase-9 activation prior to loss of
MMP and cytochrome c release, and ROS is involved in cy-
Fig. 3. ROS activates caspase-9 without cytochrome c involvement.
A: SK-N-MC cells were treated or untreated with 500 WM NAC
for 2 h prior to hypoxia, subjected to hypoxia for 2 h, and stained
with DCFH-DA. After washing three times, £uorescence intensity
was determined by £ow cytometry. B: Cells were treated or un-
treated with 500 WM NAC for 2 h prior to hypoxia, subjected to
hypoxia for indicated times, and harvested. Caspase-9 cleavage as-
say was performed using Ac-LEHD-pNA substrate. Enzyme-cata-
lyzed release of pNA was measured at 405 nm and fold(s) change
was presented. MeansSS.E.M. of three independent experiments are
shown. C: Cells were treated with 200 WM H2O2 for indicated times
and harvested. Immunoblots for cleaved caspase-9 product and cy-
tochrome c were performed.
Fig. 4. Caspase-9-dependent cytochrome c release in hypoxic injury.
A: SK-N-MC cells were exposed to hypoxia (left panel) for 6 h or
10 WM ceramide (right panel) in the presence or absence of caspase
inhibitors (20 WM LEHD-CHO, 40 WM DEVD-CHO and 20 WM
Ac-VAD-CHO). MMP was determined using 400 nM Mitotracker.
B: Cells were exposed to hypoxia or treated with ceramide in the
presence or absence of caspase inhibitors as above for indicated
times. Immunoblots were performed after cell fractionation using
anti-cytochrome c antibody. C: Isolated mitochondria (0.5 mg of
protein/ml) were exposed to recombinant caspase-9 (2 U/ml) with or
without 100 WM Ac-LEHD-CMK or 1 WM CsA for 15 min at 25‡C
in PT-1 bu¡er. After centrifugation, the supernatants were immuno-
blotted using anti-cytochrome c antibody.
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tochrome c-independent caspase-9 activation process (Fig. 5).
In addition, activated caspase-9 induces cytochrome c release
from mitochondria via PT-independent pathway. All together,
our data suggest that mitochondrial catastrophe is secondary
to caspase activation in hypoxia.
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